Jon Adkins
Fondatore presso XenoTherapeutics, Inc.
Posizioni attive di Jon Adkins
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
XenoTherapeutics, Inc.
 XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - | |
| Presidente | - | - | |
| Direttore operativo | - | - | |
| Corporate Officer/Principal | - | - | |
| Vendite & Marketing | - | - | |
Alexis Bio LLC
 Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - |
Storia della carriera di Jon Adkins
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Operating Officer | 1 |
Settori
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Commercial Services |
Alexis Bio LLC
Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Health Technology |
- Borsa valori
- Insiders
- Jon Adkins
- Esperienza
